跳至主要内容
临床试验/SLCTR/2016/009
SLCTR/2016/009尚未招募未知

Efficacy of cimetidine compared to standard therapy in reducing dapsone induced hematological adverse effects among chronic dapsone users

ady Ridgeway Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients aged 10-60 years
  • 2. Long-term dapsone therapy (>3 months) indicated [e.g. in leprosy, auto-immune blistering diseases (pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, linear IgA disease), vasculitis]

排除标准

  • 1.Diagnosed liver disease and/or any degree of elevated AST/ALT at
  • recruitment
  • 2.Diagnosed renal disease and/or any degree of elevated serum creatinine at recruitment
  • 3.Haemoglobin <10g/dl
  • 4. Cytopaenias and/or other haematological diseases (lymphoproliferative/myeloproliferative)
  • 5. Diabetes Mellitus
  • 6. Epilepsy
  • 7. Cardiac disease (NYHA grade 2 and above)
  • 8. Diagnosed psychiatric illness
  • 9. Prisoners and other institutionalized patients
  • 10. Patients currently on any long term medications

研究者

发起方
ady Ridgeway Hospital

相似试验